Isabella Gashaw

5PUBLICATIONS
12CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsWastewater treatment processesAutonomic nervous systemMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 23, 2025
Pharmacodynamics of vicadrostat for aldosterone synthase inhibition in patients with CKD.

Isabella A Gashaw, Katherine R Tuttle, Manuel Monroy Kuhn

|Nov 27, 2025
Urine Extracellular Vesicle miRNA Changes Induced by Vicadrostat with/Without Empagliflozin in Patients with Chronic Kidney Disease.

Denis Delic, Isabella Gashaw, Ileana Duran-Fernandez

|May 16, 2024
Non-invasive biomarkers prognostic of decompensation events in NASH cirrhosis: a systematic literature review.

Mattia Amoroso, Salvador Augustin, Sven Moosmang

|Jul 09, 2023
Hepatotoxicity of AKR1C3 Inhibitor BAY1128688: Findings from an Early Terminated Phase IIa Trial for the Treatment of Endometriosis.

Jan Hilpert, Esther Groettrup-Wolfers, Hristiyan Kosturski

|Apr 19, 2022
First-in-human study of eliapixant (BAY 1817080), a highly selective P2X3 receptor antagonist: Tolerability, safety and pharmacokinetics.

Stefan Klein, Isabella Gashaw, Sybille Baumann

Pageof 1

Frequent Collaborators

2 joint publications

Katherine R Tuttle

1 joint publications

Peter Rossing

1 joint publications

Thomas Hummel

1 joint publications

Christian Friedrich